secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ceribell, Inc. (CBLL)
CIK:        0001861107
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0000950170-25-066974
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ceribell Q1 revenue $20.5M (+42% YoY); raises FY2025 guidance to $83-87M
------------------------------------------------------------------------

- Q1 total revenue $20.5M (+42% YoY); product $15.6M (+41%), subscription $4.9M (+45%).
- Net loss $12.8M ($0.36 diluted EPS) vs $8.5M ($1.56) YoY; gross margin 88% (86% prior year).
- Raised 2025 revenue guidance to $83-87M (27-33% growth over prior year).
- Cash and marketable securities $182.7M; 558 active accounts at quarter end.
- FDA 510(k) clearance for pediatric Clarity algorithm (ages 1+); received FedRAMP High authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861107/000095017025066974/0000950170-25-066974-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861107/000095017025066974/cbll-20250508.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-066974

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer